Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
about
Analysis of gene expression profiles in HeLa cells in response to overexpression or siRNA-mediated depletion of NASPHuman TFDP3, a novel DP protein, inhibits DNA binding and transactivation by E2FTDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expressionInterplay between Arabidopsis activating factors E2Fb and E2Fa in cell cycle progression and developmentIntrinsic negative cell cycle regulation provided by PIP box- and Cul4Cdt2-mediated destruction of E2f1 during S phaseE2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loopControl of cell cycle transcription during G1 and S phasesExpression of Neurogenin 1 in mouse embryonic stem cells directs the differentiation of neuronal precursors and identifies unique patterns of down-stream gene expressionCanonical and atypical E2Fs regulate the mammalian endocycleRMI1 deficiency in mice protects from diet and genetic-induced obesityE2F7 represses a network of oscillating cell cycle genes to control S-phase progressionAdipocyte hyperplasia and RMI1 in the treatment of obesity.E2F8 is a nonreceptor activator of heterotrimeric G proteins.Comparative analysis of E2F family member oncogenic activity.The balance between cell division and endoreplication depends on E2FC-DPB, transcription factors regulated by the ubiquitin-SCFSKP2A pathway in Arabidopsis.Inferring the transcriptional landscape of bovine skeletal muscle by integrating co-expression networks.E2F8 is a Potential Therapeutic Target for Hepatocellular CarcinomaMultiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling.The DREAM complex: master coordinator of cell cycle-dependent gene expression.Visualizing dynamic E2F-mediated repression in vivo.E2F in vivo binding specificity: comparison of consensus versus nonconsensus binding sites.Emerging roles of E2Fs in cancer: an exit from cell cycle controlA novel E2F-like protein involved in transcriptional activation of cyst wall protein genes in Giardia lamblia.The role of the E2F transcription factor family in UV-induced apoptosis.Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues.E2F8 promotes hepatic steatosis through FABP3 expression in diet-induced obesity in zebrafish.Unique requirement for Rb/E2F3 in neuronal migration: evidence for cell cycle-independent functionsMature T cell responses are controlled by microRNA-142.E2F2 induction in related to cell proliferation and poor prognosis in non-small cell lung carcinoma.E2F8 as a Novel Therapeutic Target for Lung CancerFunctional analysis of transcription factor binding sites in human promoters.Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells.Feedback regulation between atypical E2Fs and APC/CCdh1 coordinates cell cycle progression.E2F transcription factors and digestive system malignancies: how much do we know?E2F7 regulates transcription and maturation of multiple microRNAs to restrain cell proliferationInteraction of E2F7 transcription factor with E2F1 and C-terminal-binding protein (CtBP) provides a mechanism for E2F7-dependent transcription repressionUpregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition.A combinatorial mechanism for determining the specificity of E2F activation and repressionAtypical E2Fs: new players in the E2F transcription factor familyCell-context specific role of the E2F/Rb pathway in development and disease.
P2860
Q21245543-D4FA6769-0420-4305-B0CD-E707389AC42FQ24309023-AAB416B9-0653-4CFC-9E98-D05F9D934C05Q24318430-6AC7E7E7-3654-4C66-818B-5BF05F0C46E6Q24548233-E3799A5D-6346-4B1F-BDCE-3D0BAF5C7544Q24651172-83DA26F5-174E-4334-AD26-5E377C83B653Q24674252-540C7CCB-4E09-46FC-B864-F4DB6CA068EDQ28295030-A4FD5EDC-111D-42BC-9FCC-37A13D4001ADQ28506854-8C496760-79F1-47BC-B91B-B303BF3B7BE3Q28585165-B16862F7-2F02-40B2-8CD3-4FD4ECAFD330Q28592051-FBB3A601-AD22-4FC3-BFF9-AC275BF89C79Q28592916-2F1A8CB9-3074-454A-BA56-4D4427F0490FQ30398044-F8B83D88-3A67-4640-A3C4-E6FE49F2673EQ33280515-5CB0DFBB-3EF5-408B-ADAF-53C619B8755AQ33299478-6CEA51B9-8637-4A25-B1BE-E6E30C9979F0Q33343079-677B5684-E6CE-4DBC-A31B-7EE29CA446B0Q33507905-0F38EC49-4840-4D3D-B1DD-FDBD3C9E81B5Q33776715-A4BE712A-3D31-4261-B5C5-70533B0281B6Q33877588-23CA318F-0C5F-4E29-9C24-77466936DECDQ34356659-787E894F-E795-4D15-A333-84BD2850939FQ34718099-87898748-2D30-491E-A2E0-36CD1BB36EDAQ34845654-F6B319AC-7A45-4699-90F0-DB6FEAB1CADCQ35009182-C8DCA8A6-D961-437E-A902-FF77B5F57FE2Q35310584-720987A7-3114-4542-BCD6-3F673BE6BF42Q35669509-A4626CA6-DEE7-486D-832E-5208027C55D9Q35676302-85B719BB-E513-4EB7-8EB9-C8A4FCC8402DQ35686638-2B1C1803-F4C3-4A11-99A6-EC1A3C149AFBQ35948178-9ACCA78B-BE1D-4B5B-A295-0F3944BB7D43Q36040220-51ED0116-40DC-4939-AF92-4F5369240753Q36261436-8BF277B5-13CB-4710-BC8A-A68D336C9E4DQ36294944-56DB4FFE-FA54-4932-BCBD-814912569BDFQ36378033-451AB4C1-FFA9-4054-AA77-5A3E60B7CC03Q36471410-2E39BA26-72BA-4C01-A929-1AA901DFFAE5Q36636175-7DE2ECF8-012F-40E2-BEA9-F2EB03B4AE04Q36897885-49D18025-7699-468D-8177-6138D1FE1F83Q37076251-29D5B8A4-5466-4337-86BD-EC9C7695B2EEQ37112680-2A5490E7-0954-4987-908D-6066FE89AE25Q37269121-AF5DC07E-D8A8-4FB1-AE17-9102515E00CDQ37305228-D2265CE0-B3F6-4619-AAAB-3E5EC280A20FQ37388181-F71B7208-9D2B-4117-A914-5210652D6A4AQ37606415-A445FA2B-247E-4268-950C-BEFBDE14FD04
P2860
Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Characterization of E2F8, a no ...... of E2F-activated transcription
@nl
Characterization of E2F8, a no ...... f E2F-activated transcription.
@ast
Characterization of E2F8, a no ...... f E2F-activated transcription.
@en
Characterization of E2F8, a no ...... f E2F-activated transcription.
@en-gb
type
label
Characterization of E2F8, a no ...... of E2F-activated transcription
@nl
Characterization of E2F8, a no ...... f E2F-activated transcription.
@ast
Characterization of E2F8, a no ...... f E2F-activated transcription.
@en
Characterization of E2F8, a no ...... f E2F-activated transcription.
@en-gb
prefLabel
Characterization of E2F8, a no ...... of E2F-activated transcription
@nl
Characterization of E2F8, a no ...... f E2F-activated transcription.
@ast
Characterization of E2F8, a no ...... f E2F-activated transcription.
@en
Characterization of E2F8, a no ...... f E2F-activated transcription.
@en-gb
P2093
P2860
P3181
P356
P1476
Characterization of E2F8, a no ...... f E2F-activated transcription.
@en
P2093
David Klinkenberg
Emmanuelle Trinh
Jesper Christensen
Luisa Di Stefano
Mel Heeran
Paul Cloos
Ulla Toftegaard
P2860
P304
P3181
P356
10.1093/NAR/GKI855
P407
P577
2005-09-22T00:00:00Z